Sec Form 4 Filing - Warburg Pincus X, L.P. @ Outset Medical, Inc. - 2020-09-17

Every director, officer or owner of more than ten percent of a class of equity securities registered under Section 12 of the '34 Act must file with the U.S. Securities and Exchange Commission (SEC) a statement of ownership regarding such security.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
The following is an SEC EDGAR document rendered as filed.
Here is the list of insider trading transaction codes.

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person *
Warburg Pincus X, L.P.
2. Issuer Name and Ticker or Trading Symbol
Outset Medical, Inc. [ OM]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE
3. Date of Earliest Transaction (MM/DD/YY)
09/17/2020
(Street)
NEW YORK, NY10017
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__ X __ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/17/2020 C 198,238 A 278,111 I ( 1 ) ( 3 ) ( 4 ) ( 5 ) See footnotes ( 1 ) ( 3 ) ( 4 ) ( 5 )
Common Stock 09/17/2020 C 6,196,571 A 8,693,251 I ( 2 ) ( 3 ) ( 4 ) ( 5 ) See footnotes ( 2 ) ( 3 ) ( 4 ) ( 5 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Redeemable Convertible Preferred Stock ( 6 ) 09/17/2020 C 1,235,350 ( 6 ) ( 6 ) Common Stock 117,283 $ 0 0 I ( 1 ) ( 3 ) ( 4 ) ( 5 ) See footnotes ( 1 ) ( 3 ) ( 4 ) ( 5 )
Series A Redeemable Convertible Preferred Stock ( 6 ) 09/17/2020 C 38,614,650 ( 6 ) ( 6 ) Common Stock 3,666,039 $ 0 0 I ( 2 ) ( 3 ) ( 4 ) ( 5 ) See footnotes ( 2 ) ( 3 ) ( 4 ) ( 5 )
Series B Redeemable Convertible Preferred Stock ( 7 ) 09/17/2020 C 365,041 ( 7 ) ( 7 ) Common Stock 41,587 $ 0 0 I ( 1 ) ( 3 ) ( 4 ) ( 5 ) See footnotes ( 1 ) ( 3 ) ( 4 ) ( 5 )
Series B Redeemable Convertible Preferred Stock ( 7 ) 09/17/2020 C 11,410,489 ( 7 ) ( 7 ) Common Stock 1,299,946 $ 0 0 I ( 2 ) ( 3 ) ( 4 ) ( 5 ) See footnotes ( 2 ) ( 3 ) ( 4 ) ( 5 )
Series C Redeemable Convertible Preferred Stock ( 8 ) 09/17/2020 C 179,433 ( 8 ) ( 8 ) Common Stock 22,713 $ 0 0 I ( 1 ) ( 3 ) ( 4 ) ( 5 ) See footnotes ( 1 ) ( 3 ) ( 4 ) ( 5 )
Series C Redeemable Convertible Preferred Stock ( 8 ) 09/17/2020 C 5,608,720 ( 8 ) ( 8 ) Common Stock 709,965 $ 0 0 I ( 2 ) ( 3 ) ( 4 ) ( 5 ) See footnotes ( 2 ) ( 3 ) ( 4 ) ( 5 )
Series D Redeemable Convertible Preferred Stock ( 9 ) 09/17/2020 C 99,678 ( 9 ) ( 9 ) Common Stock 16,655 $ 0 0 I ( 1 ) ( 3 ) ( 4 ) ( 5 ) See footnotes ( 1 ) ( 3 ) ( 4 ) ( 5 )
Series D Redeemable Convertible Preferred Stock ( 9 ) 09/17/2020 C 3,115,757 ( 9 ) ( 9 ) Common Stock 520,621 $ 0 0 I ( 2 ) ( 3 ) ( 4 ) ( 5 ) See footnotes ( 2 ) ( 3 ) ( 4 ) ( 5 )
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Warburg Pincus X, L.P.
C/O WARBURG PINCUS LLC
450 LEXINGTON AVENUE
NEW YORK, NY10017
X X
Warburg Pincus Partners GP LLC
C/O WARBURG PINCUS LLC
450 LEXINGTON AVENUE
NEW YORK, NY10017
X X
Warburg Pincus X Partners, L.P.
C/O WARBURG PINCUS LLC
450 LEXINGTON AVENUE
NEW YORK, NY10017
X X
Warburg Pincus Private Equity X, L.P.
C/O WARBURG PINCUS LLC
450 LEXINGTON AVENUE
NEW YORK, NY10017
X X
WPX GP, L.P.
C/O WARBURG PINCUS LLC
450 LEXINGTON AVENUE
NEW YORK, NY10017
X X
Warburg Pincus X GP L.P.
C/O WARBURG PINCUS LLC
450 LEXINGTON AVENUE
NEW YORK, NY10017
X X
WP X Finance, L.P.
C/O WARBURG PINCUS LLC
450 LEXINGTON AVENUE
NEW YORK, NY10017
X X
WPP GP LLC
C/O WARBURG PINCUS LLC
450 LEXINGTON AVENUE
NEW YORK, NY10017
X X
Warburg Pincus Partners, L.P.
C/O WARBURG PINCUS LLC
450 LEXINGTON AVENUE
NEW YORK, NY10017
X X
WARBURG PINCUS & CO.
C/O WARBURG PINCUS LLC
450 LEXINGTON AVENUE
NEW YORK, NY10017
X X
Signatures
WARBURG PINCUS X, L.P. By: WP X GP L.P., its gp By: WPP GP LLC, its gp By: WPP, L.P., its mm By: WPP GP LLC, its gp By: WP & Co., its mm By: /s/ Robert B. Knauss Name: Robert B. Knauss Title: Partner 09/17/2020
** Signature of Reporting Person Date
WARBURG PINCUS PARTNERS GP LLC By: Warburg Pincus & Co., its managing member By: /s/ Robert B. Knauss Name: Robert B. Knauss Title: Partner 09/17/2020
** Signature of Reporting Person Date
WARBURG PINCUS X PARTNERS, L.P. By: WP X, L.P., its gp By: WP X GP L.P., its gp By: WPP GP LLC, its gp By: WPP, L.P., its mm By: WPP GP LLC, its gp By: WP & Co., its mm By: /s/ Robert B. Knauss Name: Robert B. Knauss Title: Partner 09/17/2020
** Signature of Reporting Person Date
WARBURG PINCUS PRIVATE EQUITY X, L.P. By: WP X, L.P., its gp By: WP X GP L.P., its gp By: WPP GP LLC, its gp By: WPP, L.P., its mm By: WPP GP LLC, its gp By: WP & Co., its mm By: /s/ Robert B. Knauss Name: Robert B. Knauss Title: Partner 09/17/2020
** Signature of Reporting Person Date
WPX GP, L.P. By: WP X, its gp By: WP X LP, its gp By: WP X GP L.P., its gp By: WPP GP LLC, its gp By: WPP, L.P., its mm By: WPP GP LLC, its gp By: WP & Co., its mm By: /s/ Robert B. Knauss Name: Robert B. Knauss Title: Partner 09/17/2020
** Signature of Reporting Person Date
WARBURG PINCUS X GP L.P. By: WPP GP LLC, its gp By: WPP, L.P., its mm By: WPP GP LLC, its gp By: WP & Co., its mm By: /s/ Robert B. Knauss Name: Robert B. Knauss Title: Partner 09/17/2020
** Signature of Reporting Person Date
WP X FINANCE, L.P. By: WPX GP, its mg gp By: WP X, its gp By: WP X LP, its gp By: WP X GP L.P., its gp By: WPP GP LLC, its gp By: WPP, L.P., its mm By: WPP GP LLC, its gp By: WP & Co., its mm By: /s/ Robert B. Knauss Name: Robert B. Knauss Title: Partner 09/17/2020
** Signature of Reporting Person Date
WPP GP LLC By: Warburg Pincus Partners, L.P., its managing member By: Warburg Pincus Partners GP LLC, its general partner By: Warburg Pincus & Co., its managing member By: /s/ Robert B. Knauss Name: Robert B. Knauss Title: Partner 09/17/2020
** Signature of Reporting Person Date
WARBURG PINCUS PARTNERS, L.P. By: Warburg Pincus Partners GP LLC, its general partner By: Warburg Pincus & Co., its managing member By: /s/ Robert B. Knauss Name: Robert B. Knauss Title: Partner 09/17/2020
** Signature of Reporting Person Date
WARBURG PINCUS & CO. By: /s/ Robert B. Knauss Name: Robert B. Knauss Title: Partner 09/17/2020
** Signature of Reporting Person Date
Explanation of Responses:
( 1 )These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners").
( 2 )These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP.
( 3 )Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds.
( 4 )Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities."
( 5 )Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act.
( 6 )The Series A redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series A redeemable convertible preferred stock converted into approximately 0.0949 Shares. These shares had no expiration date.
( 7 )The Series B redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series B redeemable convertible preferred stock converted into approximately 0.1139 Shares. These shares had no expiration date.
( 8 )The Series C redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series C redeemable convertible preferred stock converted into approximately 0.1266 Shares. These shares had no expiration date.
( 9 )The Series D redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series D redeemable convertible preferred stock converted into approximately 0.1671 Shares. These shares had no expiration date.

Remarks:
Due to the limitations of the SEC EDGAR filing system, WP LLC is filing a separate Form 4 from the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, and WP.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.